Qol Holdings Co (TSE:3034) ROCE % : 17.67% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Qol Holdings Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Qol Holdings Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 17.67%.

Qol Holdings Co ROCE % Historical Data

The historical data trend for Qol Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qol Holdings Co ROCE % Chart

Qol Holdings Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

12.84

12.59

11.12

16.00

15.34

Qol Holdings Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															19.02	15.68	11.98	10.69	17.67

Qol Holdings Co ROCE % Calculation

Qol Holdings Co's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	9673	/	( ( (95984 - 35460)	+	(101905 - 36330) )	/ 2 )
	=	9673	/	( (60524	+	65575)	/ 2 )
	=	9673	/	63049.5
	=	15.34 %

Qol Holdings Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	11752	/	( ( (107365 - 43490)	+	(115922 - 46767) )	/ 2 )
	=	11752	/	( ( 63875	+	69155 )	/ 2 )
	=	11752	/	66515
	=	17.67 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Qol Holdings Co (TSE:3034) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Qol Holdings Co ROCE % Related Terms

Thank you for viewing the detailed overview of Qol Holdings Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Qol Holdings Co (TSE:3034) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qol Holdings Co Ltd (TSE:3034) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-3-1, Toranomon, 37th Floor, Shiroyama Trust Tower, Minato-ku, Tokyo, JPN, 105-8452

Website

https://www.qolhd.co.jp

Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.

Qol Holdings Co (TSE:3034) Headlines

No Headlines